Dynamic Microsimulation Models for Health Outcomes
暂无分享,去创建一个
[1] A Tsodikov,et al. A population model of prostate cancer incidence , 2006, Statistics in medicine.
[2] G. Friedman,et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.
[3] Ruth Etzioni,et al. Simulation modeling of outcomes and cost effectiveness. , 2000, Hematology/oncology clinics of North America.
[4] J D Habbema,et al. Model building on the basis of Dutch cervical cancer screening data. , 1985, Maturitas.
[5] Amy B. Knudsen,et al. Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.
[6] M. Zelen,et al. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. , 2005, Biostatistics.
[7] Nanda Piersma,et al. Estimating Parameters of a Microsimulation Model for Breast Cancer Screening Using the Score Function Method , 2000, Ann. Oper. Res..
[8] G. Orcutt,et al. A new type of socio-economic system , 1957 .
[9] O S Miettinen,et al. Early lung cancer action project: a summary of the findings on baseline screening. , 2001, The oncologist.
[10] Marvin Zelen,et al. Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer , 1998 .
[11] E Ackerman,et al. Simulation of stochastic micropopulation models--I. The SUMMERS simulation shell. , 1993, Computers in biology and medicine.
[12] Joshua M. Epstein,et al. Containing a large bioterrorist smallpox attack: a computer simulation approach. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[13] David J. Vanness,et al. The need for microsimulation to evaluate osteoporosis interventions , 2005, Osteoporosis International.
[14] E Ackerman,et al. Simulation of stochastic micropopulation models--II. VESPERS: epidemiological model implementations for spread of viral infections. , 1993, Computers in biology and medicine.
[15] D. McGee,et al. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. , 1990, Journal of the National Cancer Institute.
[16] S. Moss,et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.
[17] J. Peters,et al. Evaluating the performance of the Framingham risk equations in a population with diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[18] S. Pauker,et al. The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.
[19] Ping Zhang,et al. Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] J D Habbema,et al. The MISCAN simulation program for the evaluation of screening for disease. , 1985, Computer methods and programs in biomedicine.
[21] Brian W. Hollocks,et al. Forty years of discrete-event simulation—a personal reflection , 2006, J. Oper. Res. Soc..
[22] A J Palmer,et al. The Mt. Hood challenge: cross-testing two diabetes simulation models. , 2000, Diabetes research and clinical practice.
[23] Robert C. Lee,et al. The Need for Evolution in Healthcare Decision Modeling , 2003, Medical Care.
[24] E. Feuer,et al. The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing , 2004, Statistical methods in medical research.
[25] J. Griffiths. The Theory of Stochastic Processes , 1967 .
[26] Kara M. Kockelman,et al. From Aggregate Methods to Microsimulation , 2007 .
[27] L. Goldman,et al. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. , 1996, Circulation.
[28] J D Habbema,et al. A model for breast cancer screening , 1990, Cancer.
[29] D. Rex,et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.
[30] C. Earle,et al. Economic decision analysis model of screening for lung cancer. , 2001, European journal of cancer.
[31] Simon G Thompson,et al. Accounting for uncertainty in health economic decision models by using model averaging , 2009, Journal of the Royal Statistical Society. Series A,.
[32] R. Klein,et al. A Bayesian approach to modelling the natural history of a chronic condition from observations with intervention. , 1999, Statistics in medicine.
[33] E W Steyerberg,et al. Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation , 2004, Heart.
[34] Rob Boer,et al. The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..
[35] Randall P. Sadowski,et al. Simulation with Arena , 1998 .
[36] J D Habbema,et al. Epidemiological modelling for onchocerciasis control. , 1992, Parasitology today.
[37] G. Koëter,et al. Simulated waiting list prioritization for equitable allocation of donor lungs. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[38] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .
[39] E Goyder,et al. A review and critique of modelling in prioritising and designing screening programmes. , 2007, Health technology assessment.
[40] Ann G Zauber,et al. National Polyp Study data: Evidence for regression of adenomas , 2004, International journal of cancer.
[41] David M Eddy,et al. Accuracy versus transparency in pharmacoeconomic modelling: finding the right balance. , 2006, PharmacoEconomics.
[42] M. Zelen,et al. Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding , 1999 .
[43] S. Dewilde,et al. The Cost-Effectiveness of Screening Programs Using Single and Multiple Birth Cohort Simulations: A Comparison Using a Model of Cervical Cancer , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[44] M. Tockman,et al. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. , 2002, Chest.
[45] Marek Ancukiewicz,et al. Decision Models in Clinical Recommendations Development : the Stroke Prevention Policy , 1996 .
[46] Martina Morris,et al. Mathematical Models for HIV Transmission Dynamics: Tools for Social and Behavioral Science Research , 2008, Journal of acquired immune deficiency syndromes.
[47] Robert L Kane,et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. , 2007, JAMA.
[48] Harry J de Koning,et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.
[49] M. Kimmel,et al. The natural history of lung cancer in a periodically screened population. , 1987, Biometrics.
[50] M. Rosenberg. Competing risks to breast cancer mortality. , 2006, Journal of the National Cancer Institute. Monographs.
[51] L. Vale,et al. The Value of Myocardial Perfusion Scintigraphy in the Diagnosis and Management of Angina and Myocardial Infarction: A Probabilistic Economic Analysis , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[52] Leigh Tesfatsion,et al. Handbook of Computational Economics, Volume 2: Agent-Based Computational Economics (Handbook of Computational Economics) , 2006 .
[53] Dr David M. Eddy. Accuracy versus Transparency in Pharmacoeconomic Modelling , 2012, PharmacoEconomics.
[54] Oguzhan Alagoz,et al. Incorporating Biological Natural History in Simulation Models: Empirical Estimates of the Progression of End-Stage Liver Disease , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.
[55] Giovanni Parmigiani,et al. The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.
[56] J D Habbema,et al. The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. , 1996, The American journal of tropical medicine and hygiene.
[57] Karen M Kuntz,et al. Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.
[58] J. Savarino,et al. Bayesian Calibration of Microsimulation Models , 2009, Journal of the American Statistical Association.
[59] P. Walsh,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2003, The Journal of urology.
[60] J D Habbema,et al. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. , 1990, Computer methods and programs in biomedicine.
[61] Milton C Weinstein,et al. Empirically calibrated model of hepatitis C virus infection in the United States. , 2002, American journal of epidemiology.
[62] J Koopman. Models of Infectious Disease Agent Study , 2006 .
[63] B. Manaster. Cost-effectiveness of Bone Densitometry Followed by Treatment of Osteoporosis in Older Men , 2008 .
[64] J. Toole,et al. Development, validation, and application of a microsimulation model to predict stroke and mortality in medically managed asymptomatic patients with significant carotid artery stenosis. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[65] C. Henschke,et al. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. , 2003, Chest.
[66] Karl Claxton,et al. Probabilistic analysis and computationally expensive models: Necessary and required? , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[67] Constance F. Citro,et al. Improving information for social policy decisions : the uses of microsimulation modeling , 1994 .
[68] Deborah Schrag,et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? , 2006, Cancer.
[69] J. Habbema,et al. Cost-effectiveness of cervical cancer screening: comparison of screening policies. , 2002, Journal of the National Cancer Institute.
[70] G Parmigiani,et al. Measuring uncertainty in complex decision analysis models , 2002, Statistical methods in medical research.
[71] Sue J Goldie,et al. Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. , 2008, PharmacoEconomics.
[72] Eric Bonabeau,et al. Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[73] Lurdes Y. T. Inoue,et al. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. , 2006, Journal of the National Cancer Institute. Monographs.
[74] M. Wolfson,et al. POHEM--a framework for understanding and modelling the health of human populations. , 1994, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[75] K E Willard,et al. Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation , 1986, Medical decision making : an international journal of the Society for Medical Decision Making.
[76] M. Rosenberg. Chapter 3: Competing Risks to Breast Cancer Mortality , 2006 .
[77] P. Glasziou,et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. , 1998, BMJ.
[78] J. Berthelot,et al. Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions. , 2001, European journal of cancer.
[79] C. Ulrich,et al. Does Folic Acid Supplementation Prevent or Promote Colorectal Cancer? Results from Model-Based Predictions , 2008, Cancer Epidemiology Biomarkers & Prevention.
[80] K A Cronin,et al. Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. , 1998, Statistics in medicine.
[81] Serge P. Hoogendoorn,et al. State-of-the-art of vehicular traffic flow modelling , 2001 .
[82] John Eng,et al. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.
[83] C. Henschke. Early lung cancer action project , 2000, Cancer.
[84] Yen Lin Chia,et al. Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration , 2004, Statistical methods in medical research.
[85] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[86] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[87] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[88] I. Longini,et al. Simulation of mechanisms of viral interference in influenza. , 1990, International journal of epidemiology.
[89] Geoff Delaney,et al. The role of radiotherapy in cancer treatment , 2005, Cancer.
[90] J. Bellsey,et al. Healthcare applications of decision analytic modeling , 2000, HEPAC Health Economics in Prevention and Care.
[91] B. McNeil,et al. Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.
[92] Carolyn Pillers Dobler,et al. Mathematical Statistics , 2002 .
[93] G. Koëter,et al. Cost‐Effectiveness of Lung Transplantation in Relation to Type of End‐Stage Pulmonary Disease , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[94] A Mark Fendrick. The future of health economic modeling: have we gone too far or not far enough? , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[95] K. Michaud,et al. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. , 2006, Archives of internal medicine.
[96] Massimo Bernaschi,et al. Optimization of HAART with genetic algorithms and agent-based models of HIV infection , 2007, Bioinform..
[97] J. Yee,et al. Accuracy of ct colonography for detection of large adenomas and cancers , 2009 .